-
Company Insights
New![]()
Innovation and Patenting activity of Ace Technologies Corp Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Ace Technologies Corp Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New![]()
ACS Servicios Comunicaciones y Energia Caceres Solar PV Park
ACS Servicios Comunicaciones y Energia Caceres Solar PV Park is a solar PV project located in Extremadura, Spain. The project is owned by Sonnedix Power Holdings Ltd and was developed by ACS Servicios Comunicaciones y Energia SL. The project came online in 2021. Empower your strategies with our ACS Servicios Comunicaciones y Energia Caceres Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be...
-
Product Insights
NewACE Thailand Solar PV Park
ACE Thailand Solar PV Park is a solar PV project located in Thailand. The project is owned and being developed by Absolute Clean Energy PCL. The project is at the permitting stage. Empower your strategies with our ACE Thailand Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Company Insights
New![]()
Innovation and Patenting activity of PT Ace Hardware Indonesia Tbk Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of PT Ace Hardware Indonesia Tbk Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report...
-
Product Insights
New![]()
ACS Servicios Comunicaciones y Energia Castilla la Mancha Solar PV Park
ACS Servicios Comunicaciones y Energia Castilla la Mancha Solar PV Park is a solar PV project located in Castile-La Mancha, Spain. The project is owned by Sonnedix Power Holdings Ltd and was developed by ACS Servicios Comunicaciones y Energia SL. The project came online in 2019. Empower your strategies with our ACS Servicios Comunicaciones y Energia Castilla la Mancha Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ACE-1702 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ACE-1702 in Solid Tumor Drug Details: ACE-1702 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AC-203 in Epidermolysis Bullosa
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.AC-203 in Epidermolysis BullosaDrug Details:Diacerein (AC-203) is under development for the treatment of epidermolysis bullosa simplex....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AC-00058 in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.AC-00058 in Rheumatoid ArthritisDrug Details:AC-058 (AC-0058TA) is under development for the treatment of systemic lupus erythematosus...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AC-0676 in Follicular Lymphoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AC-0676 in Follicular Lymphoma Drug Details: AC-0676 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AC-699 in Metastatic Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AC-699 in Metastatic Breast Cancer Drug Details:AC-699 is under development for the treatment of estrogen receptor...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.